2m 2m 2m 2m 2m 2m 2m
NEKTAR THERAPEUT (NKTR)
NASDAQ
$70.48-$0.20 (-0.28%)
Price as of Aug 03, 2026 7:34 AM EDT- $2.4BMarket Cap
- 207.80%1-Year Change
- BiotechnologyIndustry
NEKTAR THERAPEUT (NKTR)
$70.48-$0.20 (-0.28%)
NKTR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $70.67 | ||
Change | -$0.78 (-1.09%) | ||
Open | $70.84 | ||
High | $71.42 | ||
Low | $69.50 | ||
Previous Close | $71.45 | ||
Volume | 497,236 | ||
30-Day Average Volume | 848,835 | ||
1-Week Change | -0.08% | ||
1-Month Change | 1.23% | ||
1-Year Change | 207.80% | ||
3-Year Change | 779.31% | ||
5-Year Change | -70.16% | ||
Fundamentals | |||
Shares Outstanding | 33.8M | ||
Total Assets | $763.3M | ||
Market Cap | $2.4B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $10.9M | ||
Net Income | -$44.9M | ||
Free Cash Flow | -$44.3M | ||
EBIT | -$44.8M | ||
EBITDA | -$44.7M | ||
Net Working Capital | $531.3M | ||
EPS | -$1.82 | ||
Enterprise Value/EBITDA | -50 | ||
Enterprise Value/Revenue | 206 | ||
P/B | 4 | ||
P/E | -39 | ||
PEG | 0 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 06/09/2025 | ||
Earnings & Revenue